Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Clinical trial NCT06044311 · SUSPENDED

Trial details

NCT number: NCT06044311
Sponsor: Melissa Lumish
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Esophagus Locally Advanced Adenocarcinoma Siewert Type I Adenocarcinoma of Esophagogastric Junction Siewert Type II Adenocarcinoma of Esophagogastric Junction

Start date: 2024-09-30
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.